Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients.

Sci Rep · 2021 · PMC8119733 · PMID 33986377

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For participants with obesity and T2DM, GLP-1 RA administration was associated with a lower incidence of MACE (RR 0.89 [0.81–0.98]), whereas SGLT-2 inhibitor administration showed a trend (RR 0.91 [0.83–1.00]).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.